Back to articles
Comparative guide · 6 min read

Hawthorn vs Aged Garlic for blood pressure — herbal cardio compared

Updated 2026-05-14 · Reviewed by SupplementScore editors · No sponsorships

For mildly elevated blood pressure, aged garlic extract (Kyolic) has the more consistent meta-analytic evidence — modest systolic reductions of 7–10 mmHg in hypertensive adults at 600–1,500 mg/day. Hawthorn's stronger trial signal is in mild heart failure (NYHA II), where it has modest functional-capacity evidence; its antihypertensive signal is smaller and less consistent. Both can adjunct to lifestyle and medications, neither replaces an ACE inhibitor or thiazide where one is indicated.

Quick verdict

GoalBetter choiceWhy
Mildly elevated BP (~130–145 systolic), no comorbiditiesAged garlic extractMeta-analyses show ~7–10 mmHg systolic reduction; effect more reliable than hawthorn for BP.
Mild systolic heart failure (NYHA II)Hawthorn berrySPICE and other trials show small functional-capacity improvement (6-min walk, exercise tolerance).
Mild palpitations / "anxiety-related cardiovascular complaints"HawthornTraditional use plus small RCTs of WS 1442 standardised extract; signal modest.
Lipids alongside BPAged garlicModest total-cholesterol reduction in meta-analyses; adjunctive to statins.
Combination with antihypertensivesEither, with monitoringBoth can additively lower BP — recheck readings if added on top of medications.
Anticoagulant interaction riskHawthorn (slight edge — less reported)Aged garlic has mild antiplatelet activity; modest pre-operative bleeding signal in case series.

How they actually work

Aged garlic extract — odorless, S-allyl-cysteine-standardised

Aged garlic extract (the Kyolic-style preparation) is fresh garlic aged 10–20 months in ethanol, which converts the volatile irritating sulfur compounds (allicin) into more stable, water-soluble organosulfur compounds — predominantly S-allyl-cysteine (SAC) and S-allyl-mercaptocysteine. SAC is the marker compound trialled in clinical studies. The proposed antihypertensive mechanism is enhanced endothelial nitric-oxide signaling and mild ACE-inhibitor-like activity. Trials use 600–1,500 mg/day of standardised extract; meta-analyses (Ried 2020 and earlier) consistently show systolic reductions in hypertensive participants.

Hawthorn (Crataegus monogyna, C. oxyacantha) — oligomeric procyanidins and flavonoids

Hawthorn leaf-and-flower extracts (the WS 1442 standardised preparation is the most-studied) contain oligomeric procyanidins, flavonoids (hyperoside, vitexin, rutin), and triterpene acids. The proposed cardiac mechanism is mild positive inotropic effect (similar in direction to digitalis but at a fraction of the potency), coronary vasodilation, and antioxidant activity. The heart-failure trial program (SPICE, HERB CHF, and others) shows small functional improvements in NYHA II patients on standard therapy. The antihypertensive signal is smaller — meta-analyses show 1–4 mmHg systolic reductions, less consistent than aged garlic.

The heart-failure caveat for hawthorn

The HERB CHF trial in advanced (NYHA III–IV) heart failure was negative for hard endpoints — hawthorn did not reduce mortality and may have modestly increased a composite of HF events. The functional-capacity benefits in NYHA II do not translate to mortality benefit at any stage, and hawthorn is not appropriate as a replacement for guideline-directed HF therapy (ACEi, beta-blocker, SGLT2 inhibitor, MRA). It can sit alongside in mild cases; it is not a substitute.

Magnitude of expected effect

Aged garlic at 1,200–1,500 mg/day in hypertensive adults: roughly 7–10 mmHg systolic, 4–6 mmHg diastolic reduction. Hawthorn at 900–1,800 mg standardised extract/day: roughly 1–4 mmHg systolic reduction in hypertension trials, more meaningful improvements in 6-minute walk and exercise tolerance in mild HF trials. Lifestyle interventions (DASH diet, sodium reduction, weight loss, aerobic exercise) produce larger BP reductions than either supplement.

Practical rule. For mildly elevated BP not yet meeting medication threshold, or as adjunctive on top of lifestyle: aged garlic extract 600–1,500 mg/day. Recheck BP after 8–12 weeks. For mild stable heart failure (NYHA II) on guideline therapy, where additional functional capacity is the goal: hawthorn WS 1442 extract 900 mg/day, with cardiologist sign-off. Do not start either without telling your prescriber if you're already on antihypertensives.

Dose, form, and timing

Aged garlic extract (Kyolic-style, SAC-standardised): 600–1,500 mg/day in divided doses. Odorless preparations are preferred for adherence.

Hawthorn (WS 1442 or equivalent leaf-and-flower extract): 600–1,800 mg/day in divided doses. Onset is gradual — judge after 6–12 weeks.

Safety

Aged garlic: well-tolerated. Mild GI upset, garlic odor (less with aged vs raw), and mild antiplatelet effect. Discontinue 7–10 days before elective surgery. Use cautiously with anticoagulants.

Hawthorn: well-tolerated. Mild GI upset, headache, palpitations (rare and paradoxical). The hawthorn-digoxin interaction is theoretical (additive inotropic action) — clinically uncommon at typical doses but worth knowing in patients on digoxin. Avoid in pregnancy due to insufficient data.

What to skip

Raw-garlic-bulb supplements not standardised to SAC (allicin yields vary wildly and the "allicin potential" labelling is unreliable). Hawthorn products without WS 1442 standardisation or equivalent procyanidin specification. Multi-ingredient "blood pressure support" complexes that bundle hawthorn + garlic + cinnamon + L-arginine + magnesium at subtherapeutic doses of each.

What we'd actually buy

For mild elevated BP without HF: a SAC-standardised aged garlic extract (Kyolic brand or equivalent) at 1,200 mg/day. For NYHA II heart failure on optimal medical therapy where additional functional support is the goal: WS 1442 hawthorn 900 mg/day with cardiologist sign-off. Track BP and symptoms; discontinue if no benefit at 12 weeks.

Sources